pyrroles has been researched along with Foot Dermatoses in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (72.73) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gerami, P; Guitart, J; Lacouture, ME; Reilly, LM | 1 |
Alexandrescu, DT; Anderson, RT; Atkins, MB; Dutcher, JP; Garbe, C; Guitart, J; Hauschild, A; Kong, HH; Lacouture, ME; Puzanov, I; Robert, C; Wood, L; Wu, S | 1 |
Boone, SL; Jameson, G; Lacouture, ME; Von Hoff, D | 1 |
Feyerabend, S; Schilling, D; Stenzl, A; Wicke, C | 1 |
Behnam, SE; Fife, DJ; Linden, KG; Wu, JJ | 1 |
Chang, SE; Choi, JH; Kang, YK; Koh, JK; Lee, JL; Lee, MW; Lee, WJ; Moon, KC | 1 |
Lipworth, AD; Robert, C; Zhu, AX | 1 |
Bednaríková, D; Kocák, I | 1 |
Anderson, L; Bhattacharya, S; Bose, N; Fraser, E; Graham, K; Lumsden, G; McClue, L; Robertson, L; Tho, LM; Yosef, H | 1 |
Gross, B; Hättenschwiler, A; Schulthess, G; Widmer, Ch | 1 |
Berg, BC; Chow, S; Suwattee, P; Warshaw, EM | 1 |
3 review(s) available for pyrroles and Foot Dermatoses
Article | Year |
---|---|
Evolving strategies for the management of hand-foot skin reaction associated with the multitargeted kinase inhibitors sorafenib and sunitinib.
Topics: Benzenesulfonates; Foot Dermatoses; Hand Dermatoses; Humans; Indoles; Neoplasms; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Quality of Life; Receptors, Vascular Endothelial Growth Factor; Sorafenib; Sunitinib | 2008 |
Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib.
Topics: Antineoplastic Agents; Benzenesulfonates; Drug Eruptions; Erythema; Foot Dermatoses; Hand Dermatoses; Humans; Indoles; Niacinamide; Paresthesia; Phenylurea Compounds; Prognosis; Pyridines; Pyrroles; Risk Factors; Sorafenib; Sunitinib; Syndrome | 2009 |
[Hand-foot syndrome after administration of tyrosinkinase inhibitors].
Topics: Antineoplastic Agents; Benzenesulfonates; Drug Eruptions; Foot Dermatoses; Hand Dermatoses; Humans; Indoles; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Sorafenib; Sunitinib; Syndrome | 2010 |
8 other study(ies) available for pyrroles and Foot Dermatoses
Article | Year |
---|---|
Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Female; Fluorouracil; Foot Dermatoses; Hand Dermatoses; Humans; Indoles; Kidney Neoplasms; Liver Neoplasms; Male; Middle Aged; Niacinamide; Nicotinic Acids; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Sorafenib; Sunitinib; Urea | 2008 |
Blackberry-induced hand-foot skin reaction to sunitinib.
Topics: Antineoplastic Agents; Cell Phone; Colorectal Neoplasms; Drug Eruptions; Female; Foot Dermatoses; Hand Dermatoses; Humans; Indoles; Middle Aged; Pyrroles; Sunitinib | 2009 |
Toxic dermatolysis, tissue necrosis and impaired wound healing due to sunitinib treatment leading to forefoot amputation.
Topics: Aged; Amputation, Surgical; Angiogenesis Inhibitors; Anti-Bacterial Agents; Carcinoma, Renal Cell; Cutis Laxa; Debridement; Foot Dermatoses; Forefoot, Human; Humans; Indoles; Kidney Neoplasms; Male; Nephrectomy; Pyrroles; Stevens-Johnson Syndrome; Sunitinib; Treatment Outcome; Wound Healing | 2009 |
Sunitinib-induced hand-foot syndrome: a new, distinct form.
Topics: Aged; Antineoplastic Agents; Drug Eruptions; Foot Dermatoses; Hand Dermatoses; Humans; Indoles; Male; Pyrroles; Sunitinib; Syndrome | 2010 |
Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Drug Eruptions; Female; Foot Dermatoses; Gastrointestinal Stromal Tumors; Hand Dermatoses; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Retrospective Studies; Skin Diseases; Sorafenib; Stomatitis; Sunitinib; Young Adult | 2009 |
Trastuzumab-related palmar plantar erythrodysaesthesia.
Topics: Aged; Amlodipine; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Antihypertensive Agents; Antineoplastic Agents; Atorvastatin; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Foot Dermatoses; Hand Dermatoses; Heptanoic Acids; Humans; Hypercholesterolemia; Hypertension; Pyrroles; Trastuzumab | 2012 |
["Gout tophi" and heart disease in the family].
Topics: Adult; Arcus Senilis; Atorvastatin; Cholesterol; Cholesterol, HDL; Diagnosis, Differential; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Heart Diseases; Heptanoic Acids; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Male; Middle Aged; Pyrroles; Time Factors; Xanthomatosis | 2003 |
Sunitinib: a cause of bullous palmoplantar erythrodysesthesia, periungual erythema, and mucositis.
Topics: Antineoplastic Agents; Carcinoid Tumor; Drug Eruptions; Erythema; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Immunosuppressive Agents; Indoles; Male; Middle Aged; Mouth Mucosa; Mucositis; Pyrroles; Risk Assessment; Skin Diseases, Vesiculobullous; Sunitinib; Treatment Outcome | 2008 |